Latest Competition News

Prodigy Gold NL has launched a partially underwritten entitlement offer to raise up to $6.35 million, aiming to accelerate exploration and development across its key Tanami gold projects. Major shareholders APAC Resources and Plutus Prospecting are backing the raise, with potential board changes on the horizon.

NEXTDC has increased its contracted utilisation by 16MW to 244MW, driven by new hyperscale customer contracts at its Kuala Lumpur data centre, KL1, set to launch in early 2026.

Platinum Asia Investments Limited has taken a significant step forward in its proposed restructure, lodging a draft scheme booklet to facilitate shareholder exchange of shares for ETF units. The move aims to resolve the persistent discount to net tangible assets.

Codeifai Limited is advancing talks to acquire Trust Codes Global and assets from Credissential Inc, aiming to strengthen its footprint in QR code technology and quantum AI-powered solutions.

Platinum Investment Management reported significant net outflows of approximately $1.6 billion in May 2025, driving funds under management down to $8.34 billion from $9.65 billion the previous month.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Integral Diagnostics has announced the planned retirement of CEO Dr Ian Kadish at the end of FY26, with an international search underway for his successor. The transition comes as the company focuses on integrating its recent merger with Capitol Health.

PPK Group Limited has announced the resignation of CEO Marc Fenton, who will remain in his role for six months as the company prepares a leadership transition.

Beacon Minerals Limited has announced a proposed 40, 1 share consolidation aimed at creating a more effective capital structure and enhancing its share price appeal. The move awaits shareholder approval at the July 7 general meeting.

DGL Group projects a challenging FY25 with profits down sharply despite steady revenue, as it undertakes major cost realignment and operational integration to set the stage for future growth.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Atlas Pearls reported strong sales at its June 2025 Kobe auction, achieving $6.5 million in revenue despite a lower average pearl quality index. The company’s proprietary index system showed an increase in price per quality point, underscoring sustained market demand.